Middle East & Africa Insulin Infusion Pumps Market - Growth, Trends, and Forecast (2019 - 2024)
Market Overview
The Middle East & Africa insulin infusion pumps market is set to witness a CAGR of 7%, during the forecast period. Insulin infusion pump works as an alternative to the traditional system of daily injections or an insulin pen.
Insulin infusion pumps reduce the large swings in blood glucose level (with less pain), and deliver more accurately than injections. The scheduling of meal timings is not required when using pumps.
Scope of the Report
The Middle East & Africa insulin infusion pumps market is segmented by product (insulin pump, infusion set, and reservoir) and geography.
Key Market Trends
Prevalence of Diabetes in the Middle East & Africa Region
The prevalence of diabetes mellitus has increased dramatically during the last two decades. This is due the increased prevalence of obesity, which is the primary risk factor for diabetes.
The R&D in the insulin segments are increasing year-on-year and scientists are trying to bring out the best molecule for patients use, curbing out maximum side effects and increasing its efficiency.
Although insulin is used in the treatment of diabetes for over 90 years, globally more than half of those who need insulin today still cannot afford and/or access it. People with type-1 diabetes need insulin therapy, and the treatment focuses on managing blood sugar levels with insulin, diet, and lifestyle to prevent complications.
Egypt Holds the Highest Market Share in the Middle East & Africa Insulin Infusion Pumps Market
Egypt holds the highest market share in the Middle East & Africa insulin infusion pumps market, and it is also expected to register a high CAGR of 5% in the forecast period.
In Egypt, the cost of purchasing essential insulin for people with type-1 diabetes was estimated to be 57% of the average monthly disposable income.
Competitive Landscape
Animas had to exit the insulin infusion pumps market, as the company has admitted that rising competition was the reason for it to leave the market.
Medtronic is the market leader and is expected to maintain its position during the forecast period.
Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
Report customization as per the client's requirements
3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.
- 1 INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
- 2 RESEARCH METHODOLOGY
- 3 EXECUTIVE SUMMARY
- 4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Drivers
- 4.3 Restraints
- 4.4 Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Suppliers
- 4.4.2 Bargaining Power of Consumers
- 4.4.3 Threat of New Entrants
- 4.4.4 Threat of Substitute Products and Services
- 4.4.5 Intensity of Competitive Rivalry
- 5 MARKET SEGMENTATION
- 5.1 Product (Value and Volume 2012-2024)
- 5.1.1 Insulin Pump
- 5.1.2 Infusion Set
- 5.1.3 Reservoir
- 5.2 Geography
- 5.2.1 Middle East & Africa (MEA)
- 5.2.1.1 Saudi Arabia (Value and Volume 2012-2024)
- 5.2.1.1.1 By Insulin Pump
- 5.2.1.1.2 By Infusion Set
- 5.2.1.1.3 By Reservoir
- 5.2.1.2 South Africa (Value and Volume 2012-2024)
- 5.2.1.2.1 By Insulin Pump
- 5.2.1.2.2 By Infusion Set
- 5.2.1.2.3 By Reservoir
- 5.2.1.3 Iran (Value and Volume 2012-2024)
- 5.2.1.3.1 By Insulin Pump
- 5.2.1.3.2 By Infusion Set
- 5.2.1.3.3 By Reservoir
- 5.2.1.4 Egypt (Value and Volume 2012-2024)
- 5.2.1.4.1 By Insulin Pump
- 5.2.1.4.2 By Infusion Set
- 5.2.1.4.3 By Reservoir
- 5.2.1.5 Oman (Value and Volume 2012-2024)
- 5.2.1.5.1 By Insulin Pump
- 5.2.1.5.2 By Infusion Set
- 5.2.1.5.3 By Reservoir
- 5.2.1.6 Rest of MEA (Value and Volume 2012-2024)
- 5.2.1.6.1 By Insulin Pump
- 5.2.1.6.2 By Infusion Set
- 5.2.1.6.3 By Reservoir
- 6 MARKET INDICATORS
- 6.1 Type-1 Diabetes Population (2012-2024)
- 6.2 Type-2 Diabetes Population (2012-2024)
- 7 COMPETITIVE LANDSCAPE
- 7.1 COMPANY PROFILES
- 7.1.1 Medtronic
- 7.1.2 Insulet
- 7.1.3 Roche
- 7.1.4 Animas
- 7.1.5 Tandem
- 7.1.6 Ypsomed
- 7.1.7 Cellnovo
- 7.2 COMPANY SHARE ANALYSIS
- 7.2.1 Roche
- 7.2.2 Animas
- 7.2.3 Medtronic
- 7.2.4 Other Companies
- 8 MARKET OPPORTUNITIES AND FUTURE TRENDS
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook